SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, recognizing the company's excellence in innovation, commercial success, industry leadership and positive societal impact. The award highlights the growing adoption of the SSi Mantra surgical robotic system, which the company believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also noted that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. To view the full press release, visit https://ibn.fm/XWdRe.
The SSi Mantra system is part of SS Innovations' broader product range, which includes the proprietary "SSi Mudra" surgical instruments supporting a variety of procedures including cardiac surgery. The company, an American firm headquartered in India, aims to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available on the company's website at ssinnovations.com.
This award matters because it signals increasing market validation for SS Innovations' approach to making robotic surgery more accessible. With over 11,700 procedures completed and a growing physician training base, the SSi Mantra system is demonstrating real-world utility across multiple specialties, including complex cardiac and pediatric surgeries. The company's emphasis on cost efficiency could help expand robotic surgery to regions where high costs have been a barrier. Furthermore, the inclusion of telesurgeries points to potential for remote surgical care, which could broaden access in underserved areas.
Forward-looking statements in the release are subject to risks and uncertainties, including those detailed in the company's SEC filings. Please see full terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
